CN109295028B - 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 - Google Patents
高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 Download PDFInfo
- Publication number
- CN109295028B CN109295028B CN201811305138.7A CN201811305138A CN109295028B CN 109295028 B CN109295028 B CN 109295028B CN 201811305138 A CN201811305138 A CN 201811305138A CN 109295028 B CN109295028 B CN 109295028B
- Authority
- CN
- China
- Prior art keywords
- ala
- val
- mutant
- aspartokinase
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010055400 Aspartate kinase Proteins 0.000 title claims abstract description 93
- 108010064711 Homoserine dehydrogenase Proteins 0.000 title claims abstract description 56
- 230000000694 effects Effects 0.000 title claims abstract description 32
- 241000894006 Bacteria Species 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 46
- 102000004190 Enzymes Human genes 0.000 claims abstract description 46
- 150000001413 amino acids Chemical group 0.000 claims abstract description 31
- 229940024606 amino acid Drugs 0.000 claims abstract description 18
- 241000186216 Corynebacterium Species 0.000 claims abstract description 17
- 230000035772 mutation Effects 0.000 claims abstract description 17
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 8
- 238000013537 high throughput screening Methods 0.000 claims abstract description 5
- 238000005215 recombination Methods 0.000 claims abstract 2
- 230000006798 recombination Effects 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 29
- 239000000047 product Substances 0.000 claims description 23
- 241000572303 Corynebacterium pekinense Species 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000013612 plasmid Substances 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000010276 construction Methods 0.000 claims description 12
- 238000011144 upstream manufacturing Methods 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 5
- 108091008146 restriction endonucleases Proteins 0.000 claims description 5
- 238000001976 enzyme digestion Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000001042 affinity chromatography Methods 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 210000002429 large intestine Anatomy 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 238000002525 ultrasonication Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 20
- 238000000855 fermentation Methods 0.000 abstract description 19
- 230000004151 fermentation Effects 0.000 abstract description 19
- 230000005764 inhibitory process Effects 0.000 abstract description 10
- 239000013604 expression vector Substances 0.000 abstract description 6
- 238000007792 addition Methods 0.000 abstract description 3
- 238000012217 deletion Methods 0.000 abstract description 3
- 230000037430 deletion Effects 0.000 abstract description 3
- 238000006467 substitution reaction Methods 0.000 abstract description 3
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 abstract description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract description 2
- 125000000539 amino acid group Chemical group 0.000 abstract description 2
- 230000003578 releasing effect Effects 0.000 abstract 1
- 230000003313 weakening effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 16
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 15
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 14
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 13
- 108010005233 alanylglutamic acid Proteins 0.000 description 12
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 8
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 8
- 108010047495 alanylglycine Proteins 0.000 description 8
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 108010078274 isoleucylvaline Proteins 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 239000004473 Threonine Substances 0.000 description 7
- 229960002898 threonine Drugs 0.000 description 7
- 239000004472 Lysine Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- 229960005261 aspartic acid Drugs 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 229960000310 isoleucine Drugs 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229960004452 methionine Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 4
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 4
- WJRXVTCKASUIFF-FXQIFTODSA-N Ala-Cys-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WJRXVTCKASUIFF-FXQIFTODSA-N 0.000 description 4
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 4
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 4
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 4
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 4
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 4
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 4
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 4
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 4
- NVUIWHJLPSZZQC-CYDGBPFRSA-N Arg-Ile-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NVUIWHJLPSZZQC-CYDGBPFRSA-N 0.000 description 4
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 4
- ZDOQDYFZNGASEY-BIIVOSGPSA-N Asn-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZDOQDYFZNGASEY-BIIVOSGPSA-N 0.000 description 4
- IYVSIZAXNLOKFQ-BYULHYEWSA-N Asn-Asp-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IYVSIZAXNLOKFQ-BYULHYEWSA-N 0.000 description 4
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 4
- PQKSVQSMTHPRIB-ZKWXMUAHSA-N Asn-Val-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O PQKSVQSMTHPRIB-ZKWXMUAHSA-N 0.000 description 4
- FRSGNOZCTWDVFZ-ACZMJKKPSA-N Asp-Asp-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O FRSGNOZCTWDVFZ-ACZMJKKPSA-N 0.000 description 4
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 4
- SPWXXPFDTMYTRI-IUKAMOBKSA-N Asp-Ile-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SPWXXPFDTMYTRI-IUKAMOBKSA-N 0.000 description 4
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 4
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 4
- PLOKOIJSGCISHE-BYULHYEWSA-N Asp-Val-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLOKOIJSGCISHE-BYULHYEWSA-N 0.000 description 4
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 4
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 4
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 4
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 4
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 4
- VTTSANCGJWLPNC-ZPFDUUQYSA-N Glu-Arg-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VTTSANCGJWLPNC-ZPFDUUQYSA-N 0.000 description 4
- RFDHKPSHTXZKLL-IHRRRGAJSA-N Glu-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N RFDHKPSHTXZKLL-IHRRRGAJSA-N 0.000 description 4
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 4
- KRGZZKWSBGPLKL-IUCAKERBSA-N Glu-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N KRGZZKWSBGPLKL-IUCAKERBSA-N 0.000 description 4
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 4
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 4
- VGBSZQSKQRMLHD-MNXVOIDGSA-N Glu-Leu-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VGBSZQSKQRMLHD-MNXVOIDGSA-N 0.000 description 4
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 4
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 4
- CHDWDBPJOZVZSE-KKUMJFAQSA-N Glu-Phe-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O CHDWDBPJOZVZSE-KKUMJFAQSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 4
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 4
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 4
- FIQQRCFQXGLOSZ-WDSKDSINSA-N Gly-Glu-Asp Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FIQQRCFQXGLOSZ-WDSKDSINSA-N 0.000 description 4
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 4
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 4
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 4
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 4
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 4
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 4
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 4
- QCBYAHHNOHBXIH-UWVGGRQHSA-N His-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CN=CN1 QCBYAHHNOHBXIH-UWVGGRQHSA-N 0.000 description 4
- CCHSQWLCOOZREA-GMOBBJLQSA-N Ile-Asp-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N CCHSQWLCOOZREA-GMOBBJLQSA-N 0.000 description 4
- WTOAPTKSZJJWKK-HTFCKZLJSA-N Ile-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N WTOAPTKSZJJWKK-HTFCKZLJSA-N 0.000 description 4
- TVYWVSJGSHQWMT-AJNGGQMLSA-N Ile-Leu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N TVYWVSJGSHQWMT-AJNGGQMLSA-N 0.000 description 4
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 4
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 4
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 4
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 4
- XFIHDSBIPWEYJJ-YUMQZZPRSA-N Lys-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN XFIHDSBIPWEYJJ-YUMQZZPRSA-N 0.000 description 4
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 4
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 4
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 4
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 4
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 4
- FBQMBZLJHOQAIH-GUBZILKMSA-N Met-Asp-Met Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O FBQMBZLJHOQAIH-GUBZILKMSA-N 0.000 description 4
- MTBVQFFQMXHCPC-CIUDSAMLSA-N Met-Glu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MTBVQFFQMXHCPC-CIUDSAMLSA-N 0.000 description 4
- JHDNAOVJJQSMMM-GMOBBJLQSA-N Met-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCSC)N JHDNAOVJJQSMMM-GMOBBJLQSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- JIYJYFIXQTYDNF-YDHLFZDLSA-N Phe-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N JIYJYFIXQTYDNF-YDHLFZDLSA-N 0.000 description 4
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 4
- PBXYXOAEQQUVMM-ULQDDVLXSA-N Phe-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=CC=C2)N PBXYXOAEQQUVMM-ULQDDVLXSA-N 0.000 description 4
- YDUGVDGFKNXFPL-IXOXFDKPSA-N Phe-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YDUGVDGFKNXFPL-IXOXFDKPSA-N 0.000 description 4
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 4
- NHDVNAKDACFHPX-GUBZILKMSA-N Pro-Arg-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O NHDVNAKDACFHPX-GUBZILKMSA-N 0.000 description 4
- FKLSMYYLJHYPHH-UWVGGRQHSA-N Pro-Gly-Leu Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O FKLSMYYLJHYPHH-UWVGGRQHSA-N 0.000 description 4
- YXHYJEPDKSYPSQ-AVGNSLFASA-N Pro-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 YXHYJEPDKSYPSQ-AVGNSLFASA-N 0.000 description 4
- 108010079005 RDV peptide Proteins 0.000 description 4
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 4
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 4
- CRZRTKAVUUGKEQ-ACZMJKKPSA-N Ser-Gln-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O CRZRTKAVUUGKEQ-ACZMJKKPSA-N 0.000 description 4
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 4
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 4
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 4
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 4
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 4
- GLQFKOVWXPPFTP-VEVYYDQMSA-N Thr-Arg-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GLQFKOVWXPPFTP-VEVYYDQMSA-N 0.000 description 4
- FLPZMPOZGYPBEN-PPCPHDFISA-N Thr-Leu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLPZMPOZGYPBEN-PPCPHDFISA-N 0.000 description 4
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 4
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 4
- HHPSUFUXXBOFQY-AQZXSJQPSA-N Trp-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O HHPSUFUXXBOFQY-AQZXSJQPSA-N 0.000 description 4
- NIHNMOSRSAYZIT-BPNCWPANSA-N Tyr-Ala-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NIHNMOSRSAYZIT-BPNCWPANSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 4
- SMKXLHVZIFKQRB-GUBZILKMSA-N Val-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N SMKXLHVZIFKQRB-GUBZILKMSA-N 0.000 description 4
- VMRFIKXKOFNMHW-GUBZILKMSA-N Val-Arg-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N VMRFIKXKOFNMHW-GUBZILKMSA-N 0.000 description 4
- OGNMURQZFMHFFD-NHCYSSNCSA-N Val-Asn-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N OGNMURQZFMHFFD-NHCYSSNCSA-N 0.000 description 4
- XLDYBRXERHITNH-QSFUFRPTSA-N Val-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)C(C)C XLDYBRXERHITNH-QSFUFRPTSA-N 0.000 description 4
- XEYUMGGWQCIWAR-XVKPBYJWSA-N Val-Gln-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)O)N XEYUMGGWQCIWAR-XVKPBYJWSA-N 0.000 description 4
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 4
- SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 4
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 4
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 4
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 4
- WDIWOIRFNMLNKO-ULQDDVLXSA-N Val-Leu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WDIWOIRFNMLNKO-ULQDDVLXSA-N 0.000 description 4
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 4
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 4
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 4
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 4
- RTJPAGFXOWEBAI-SRVKXCTJSA-N Val-Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RTJPAGFXOWEBAI-SRVKXCTJSA-N 0.000 description 4
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 4
- 108010044940 alanylglutamine Proteins 0.000 description 4
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 4
- 108010060035 arginylproline Proteins 0.000 description 4
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 4
- 108010092854 aspartyllysine Proteins 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 108010060199 cysteinylproline Proteins 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 108010054813 diprotin B Proteins 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 4
- 229960003646 lysine Drugs 0.000 description 4
- 108010009298 lysylglutamic acid Proteins 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 108010056582 methionylglutamic acid Proteins 0.000 description 4
- 108010005942 methionylglycine Proteins 0.000 description 4
- 108010018625 phenylalanylarginine Proteins 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108010048818 seryl-histidine Proteins 0.000 description 4
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 4
- 101150075693 AK gene Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000019766 L-Lysine Nutrition 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930182844 L-isoleucine Natural products 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- RZJOHSFAEZBWLK-CIUDSAMLSA-N Met-Gln-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N RZJOHSFAEZBWLK-CIUDSAMLSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 2
- CEKSLIVSNNGOKH-KZVJFYERSA-N Val-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C(C)C)N)O CEKSLIVSNNGOKH-KZVJFYERSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 238000012933 kinetic analysis Methods 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
- C12Y207/02004—Aspartate kinase (2.7.2.4)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
一种天冬氨酸激酶突变体、工程菌及该突变体的制备方法,属于生物工程技术领域。本发明所述的高酶活天冬氨酸激酶突变体是氨基酸序列如SEQ ID NO:2所示的外源性天冬氨酸激酶经过2~10个、进一步2~6个、再进一步2~3个氨基酸残基的取代、缺失或添加而形成的序列,且具有天冬氨酸激酶的功能。优选的是经过2个氨基酸残基的取代、缺失或添加而形成的序列,特别优选的,是对该氨基酸序列中第372位和379位的氨基酸进行定点饱和突变,并利用高通量筛选方法挑选高酶活天冬氨酸激酶突变体。本发明进一步利用电转化法将高酶活力且解除或削弱Lys反馈抑制作用的天冬氨酸激酶突变体的pEC‑AK重组穿梭表达载体转入到北京棒杆菌中,最终获得重组北京棒杆菌M372I‑T379S工程菌,并对其进行发酵产物分析。
Description
技术领域
本发明属于生物工程技术领域,具体涉及天冬氨酸激酶突变体、工程菌及该突变体的制备方法。
背景技术
天冬氨酸激酶(Aspartokinase,AK)广泛存在于细菌、真菌和植物中,是天冬氨酸族氨基酸合成途径中关键限速酶,其催化L-天冬氨酸与三磷酸腺苷(ATP)反应,生成L-天冬氨酰-4-基磷酸和腺嘌呤核苷二磷酸(ADP)。然而天冬氨酸激酶是一种别构酶,受到末端产物如苏氨酸和赖氨酸的协同反馈抑制作用,可灵活根据终产物的积累情况控制碳流量,因此限制了天冬氨酸族氨基酸的积累。
由于天冬氨酸激酶受到终产物严格的调控,解除终产物对AK的反馈抑制是发展高产末端产物蛋氨酸、苏氨酸、赖氨酸和异亮氨酸菌株的必经之路之一。
天冬氨酸族氨基酸主要采用蛋白质水解法、化学合成法和微生物发酵法生产。因蛋白质水解法和化学合成法具有环境污染严重、危险性大、资源成本高等缺点将逐渐被淘汰,而以生产成本低、环境污染小、节约能源等优点集一身的微生物发酵法逐步成为工业化生产的主要方法,因此高产天冬氨酸族氨基酸工程菌的构建成为研究的热点。
传统上,突变株通过物理或化学诱变剂作用进行随机突变和后续筛选而构建,如筛抗结构类似物和营养缺陷型突变株,但以上方法存在任务重、周期长和很难进一步提高目标物产量等问题。随着基因工程和蛋白质工程技术的发展,对关键酶进行理性或半理性设计及定向改造,从分子水平上对代谢途径进行合理的调控己成为选育高产天冬氨酸族氨基酸菌株的热门方向。例如,在CN104662169A中已报道制备含有编码在其反馈抑制中解除或者削弱酶基因载体的方法;中国专利CN 1071378 C公开了一种解除反馈抑制的天冬氨酸激酶以及利用该激酶和包含该激酶的宿主生产L-苏氨酸的方法。但寻找更多、更有效的天冬氨酸激酶仍十分重要。
综上所述,本领域急需具有高酶活和解除终产物反馈抑制能力的天冬氨酸激酶突变体。
发明内容
本发明的目的在于提供具有高酶活且解除Lys抑制作用的天冬氨酸激酶突变体和工程菌及该突变体的制备方法。
本发明成功构建了一株北京棒杆菌重组菌M372I-T379S工程菌,其保藏编号为CGMCC NO.16340,分类命名为北京棒杆菌(Corynebacterium pekinense),保藏单位为中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),地址:北京市朝阳区北辰西路1号院3号,中国科学院微生物研究所,100101),保藏日期为2018年8月27日。
外源性天冬氨酸激酶(AK)基因来源于北京棒杆菌AS1.299(购自中科院微生物研究所),其核苷酸序列如SEQ ID NO:1所示,外源性天冬氨酸激酶(AK)的氨基酸序列如SEQID NO:2所示。
本发明所述的高酶活天冬氨酸激酶突变体是氨基酸序列如SEQ ID NO:2所示的外源性天冬氨酸激酶经过2~10个、进一步2~6个、再进一步2~3个氨基酸残基的取代、缺失或添加而形成的序列,且具有天冬氨酸激酶的功能。优选的是经过2个氨基酸残基的取代、缺失或添加而形成的序列;特别优选的,是对该氨基酸序列中第372位和379位的氨基酸进行定点饱和突变(即该突变位点可任意突变为其他19种氨基酸),并利用高通量筛选方法挑选高酶活天冬氨酸激酶突变体;最终优选的是得到氨基酸序列如SEQ ID NO:8所示的突变体。
本说明所述的氨基酸序列如SEQ ID NO:2所示的外源性天冬氨酸激酶的第372位和379位的氨基酸进行定点饱和突变得到的高酶活天冬氨酸激酶突变体的制备方法,其步骤如下:
1)以北京棒杆菌(Corynebacterium pekinense)的全基因组为模板,设计引物,通过PCR反应获得核苷酸序列如SEQ ID NO:1所示的天冬氨酸激酶(AK)目的基因片段;
2)利用限制性内切酶EcoRI和NdeI对步骤1)得到的天冬氨酸激酶(AK)目的基因片段和pET-28a载体进行双酶切后并过夜连接,连接后的产物即为pET-AK重组质粒;
3)以步骤2)得到的pET-AK重组质粒为模板,利用M372N和T379N引物分别对编码AK的氨基酸序列的372位和379位氨基酸进行定点饱和突变PCR,并将PCR产物分别转入到大肠杆菌BL21(DE3)中,获得多种天冬氨酸激酶单突变体菌株,通过高通量筛选的方法挑选出高酶活力天冬氨酸激酶单突变体,即M372I和T379S菌株;
PCR引物如下(划线部分为突变位点):
M372N上游引物5’-GTAACACCTGGGTGAGACTGNNNGCCCGCACC-3’
下游引物5’-CTCGTGGGTGCGGGCNNNCAGTCTCACCC-3’
T379N上游引物5’-CATGAACTCTGCNNNAACACCTGGGTGAGACTG-3’
下游引物5’-CACCCAGGTGTTNNNGCAGAGTTCATGGAAGC-3’
4)提取单突变体M372I菌株的质粒,利用T379S上游引物5’-TTCCATGAACTCTGCGCTAACACCTGGGTGAGAC-3’,下游引物5’-CACCCAGGTGTTAGCGCAGAGTTCATGGAAGC-3’(划线部分为突变位点)进行突变PCR,并将PCR产物转入到大肠杆菌BL21(DE3)中,获得天冬氨酸激酶突变体M372I-T379S菌株。
5)添加异丙基硫代半乳糖苷(IPTG)至含有天冬氨酸激酶突变体M372I-T379S菌株的LB培养基中,过夜培养诱导蛋白表达;
6)对步骤5)得到的菌液进行离心处理,加入PBS缓冲溶液吹悬菌体,通过超声破碎、离心处理后得到的上清液即为粗酶液,经镍柱亲和层析法分离纯化,得到天冬氨酸激酶突变体AK的纯化液,即完成了该高酶活天冬氨酸激酶突变体的构建;
7)对步骤6)得到的天冬氨酸激酶突变体AK纯化液进行反应动力学、最适温度、最适pH、稳定性及抑制剂反馈抑制能力分析。
第二方面,本说明提供了一株北京棒杆菌重组菌M372I-T379S工程菌及其构建方法。
提取从步骤6)获得的高酶活力且削弱Lys反馈抑制作用AK纯化液的天冬氨酸激酶突变体M372I-T379S菌株质粒,并以其为模板,在引物(上游引物5’-CATGGAATTCATGGCCCTGGTCGTACAGAA-3’,下游引物5’-GAGGATCCTTAGCGTCCGGTGCCTGC-3’,划线部分分别为EcRI和BamHI酶切位点)的作用下进行PCR反应,将PCR产物与穿梭表达载体pEC-XK99E进行EcRI和BamHI双酶切和过夜连接,获得的连接产物即为pEC-AK重组穿梭表达载体,利用电转化法将其转至北京棒杆菌感受态中,构建的菌株即为北京棒杆菌重组菌M372I-T379S工程菌。
第三方面,本说明对工程菌进行发酵产物分析。
将工程菌(北京棒杆菌重组菌M372I-T379S)以2%(v/v)接种量转入到100mL种子培养基(葡萄糖25g/L,玉米浆20g/L,尿素1.25g/L,KH2PO4 1g/L,MgSO4 5g/L,pH 7.0),30℃、200rpm培养12后,将其以5%(v/v))接种量转接至100mL发酵培养基(葡萄糖60g/L,玉米浆20g/L,维生素B11mg/L,维生素B6 6mg/L,维生素B12 0.2g/L,生物素0.1mg/L,KH2PO4 1g/L,(NH4)2SO4 20g/L,MgSO4 0.5g/L,MnSO4 0.01g/L,FeSO4 0.01g/L,pH 7.0),使其初始OD600=1.0,30℃、200r/min培养48h,利用高效液相色谱法每4h收集发酵液进行发酵产物测定,发酵30h后发酵产物的产量趋于稳定,总氨基酸含量高达53.64g/L,其中L-蛋氨酸、L-苏氨酸、L-异亮氨酸和L-赖氨酸产量分别达到0.16g/L、2.68g/L、5.33g/L和8.39g/L。
附图说明
图1电泳验证结果图:(a)PCR核酸电泳验证结果图(M:2000DNA Marker;1,AK);(b)SDS-PAGE验证结果图(M:蛋白Marker;1,WT粗酶液;2,WT纯化液;3,M372I粗酶液;4,M372I纯化液;5,T379S粗酶液;6,T379S纯化液;7,M372I-T379S粗酶液;8,M372I-T379S纯化液);
图2野生型(WT)和突变体(M372I、T379S、M372I-T379S)的反应动力学分析曲线;
图3野生型(WT)和突变体(M372I、T379S、M372I-T379S)的最适pH曲线;
图4野生型(WT)和突变体(M372I、T379S、M372I-T379S)的最适温度曲线;
图5野生型(WT)和突变体(M372I、T379S、M372I-T379S)的稳定性曲线;
图6野生型(WT)和突变体(M372I、T379S、M372I-T379S)与抑制剂或底物分子间结合能力分析曲线,(a)野生型与底物L-Asp结合能力分析曲线,(b)M372I-T379S突变体AK与底物L-Asp结合能力分析曲线,(c)野生型AK与抑制剂Lys结合能力分析曲线,(d)M372I-T379S突变体AK与抑制剂Lys结合能力分析曲线。
具体实施方式
经过长期的研究发现源自北京棒杆菌的天冬氨酸激酶突变体不仅具有优良的比活性,还具有一定的解除赖氨酸反馈抑制能力。下面结合具体实施例,进一步阐述本说明。
实施例1、重组大肠杆菌菌株的构建
(1)AK基因的克隆
利用TAKaRa基因组提取试剂盒提取北京棒杆菌(Corynebacterium pekinense)染色体DNA,以其为模板在克隆引物作用下进行PCR扩增,大量克隆AK目的基因片段,经PCR核酸电泳验证,北京棒杆菌天冬氨酸激酶(AK)在附图1中1000到2000bp之间有明亮条带,其与SEQ ID NO:1的长度大小相符。试剂均购自TAKaRa公司,设计的克隆引物如下:
上游引物:5'-GGAATTCCATATGGCCCTGGTCGTACAGAA-3'
下游引物:5'-GGAATTCTTAGCGTCCGGTGCCTGCAT-3'
其中划线部分是NdeI和EcoRI限制性酶的酶切切位点。
(2)构建重组大肠杆菌菌株
利用胶回收试剂盒(TAKaRa)回收含AK目的基因片段的PCR产物,将其与pET-28a载体分别进行EcoRI和NdeI双酶切后,16℃恒温金属浴中进行过夜连接,获得pET-AK重组质粒。将其转入到大肠杆菌BL21感受态细胞中,获得含AK基因的重组大肠杆菌菌株。由于重组大肠杆菌菌株的AK基因未发生突变,因此本发明在后期研究中将其称为野生菌株(WT)。
连接体系如下:
感受态细胞制备:
1)将大肠杆菌BL21(DE3)菌株以2%的接种量接种至10mL不含卡那霉素的LB液体培养基中,37℃,180r/min,培养12h;
2)取步骤1)活化后的大肠杆菌BL21(DE3)菌液1mL接种至50mL不含卡那霉素的LB培养基中,37℃,200r/min培养,OD562值达至0.35;
3)将步骤2)菌液转移至预冷的无菌离心筒冰浴10min后,4℃,5000r/min离心10min,弃上清,收集菌体;
4)取50mL预冷的0.1mol/L GaCl2溶液将步骤3)菌体重悬,冰浴30min。
5)将步骤4)冰浴后的溶液4℃,5000r/min离心10min,弃上清。再加入5mL预冷的0.1mol/L GaCl2溶液,用枪头轻轻吹打重悬菌体,加1mL甘油,分装保存于-80℃冰箱中。
转化至大肠杆菌BL21(DE3)感受态细胞中:
1)取出大肠杆菌BL21(DE3)感受态细胞,冰浴条件下融化。
2)每100μL大肠杆菌BL21(DE3)感受态细胞分别加入2μL重组质粒或PCR产物,混匀,冰浴8min,42℃热激90s,再冰浴2min。
3)加入900μL不含卡那霉素的LB培养基至上述感受态细胞中,37℃,165r/min培养2h。
4)8000r/min离心2min,吸取800μL上清液,将菌体重悬,涂布于含卡那霉素LB固体培养基上,37℃培养箱培养20h。
将菌株送至上海生工生物工程有限公司进行基因测序,北京棒杆菌(Corynebacterium pekinense,Cp)天冬氨酸激酶(AK)测序结果如SEQ ID NO:1所示。
实施例2、天冬氨酸激酶突变体的构建
(1)天冬氨酸激酶M372位点突变体的构建
以实施例1(2)中的pET-AK重组质粒为模板,在M372N上游引物5’-GTAACACCTGGGTGAGACTGNNNGCCCGCACC-3’,下游引物5’-CTCGT GGGTGCGGGCNNNCAGTCTCACCC-3’(划线部分为突变位点)的作用下进行突变PCR反应,利用限制性内切酶EcoRI和NdeI对PCR产物和pET-28a载体进行双酶切后并过夜连接(利用实施例1(2)中双酶切和连接体系),将连接后的产物通过实施1(2)的方法转入到大肠杆菌BL21(DE3)感受态中,获得天冬氨酸激酶M372位点突变体菌株。
(2)天冬氨酸激酶T379位点突变体的构建
以实施例1(2)中的pET-AK重组质粒为模板,利用实施例2(1)中的PCR反应体系和扩增程序,在T379N上游引物5’-CATGAACTCTGCNNNAACACCT GGGTGAGACTG-3’下游引物5’-CACCCAGGTGTTNNNGCAGAGTTCATGGA AGC-3’(划线部分为突变位点)的作用下进行突变PCR反应,对PCR产物和pET-28a载体进行限制性内切酶EcoRI和NdeI双酶切后并过夜连接(利用实施例1(2)中双酶切和连接体系),将连接后的产物通过实施1(2)的方法转入到大肠杆菌BL21(DE3)感受态中,获得天冬氨酸激酶T379位点突变体菌株。
(3)高通量筛选高酶活突变体
将天冬氨酸激酶M372和T379位点突变体菌株的单菌落分别接种至含有200μL LB液体培养基的96孔板中,于37℃、180r/min过夜培养,加入IPTG(终浓度为1mmol/L)30℃、130r/min,培养12h诱导蛋白表达。诱导后4000r/min离心45min,弃上清,加入100μL PBS缓冲溶液重悬菌体,于-20℃、30min与30℃、50min反复冻融5次使得菌体细胞破碎,胞内蛋白流出。
以L-Asp为底物,对胞内蛋白中的AK进行酶活力测定。酶活测定体系为800mmol/LKCl、10mmol/L L-Asp、100mmol/L Tris-HCl、800mmol/L NH4OH、10mmol/Lβ-巯基乙醇、10.4mmol/L ATP、1.6mmol/L MgSO4,在上述96孔板中每孔加入100μL酶活测定体系溶液,28℃、130r/min反应30min。反应后加入等体积三氯化铁终止试剂混匀,于波长540nm下测其吸光度。
将酶活力提高明显的突变体菌株送至上海生工生物工程有限公司进行测序,其中一株高酶活天冬氨酸激酶突变体的核苷酸序列如SEQ ID NO:3所示,氨基酸序列如SEQ IDNO:4所示,对比SEQ ID NO:2和SEQ ID NO:4的氨基酸序列,发现372位点的蛋氨酸(M)突变为异亮氨酸(I),即成功构建了高酶活天冬氨酸激酶单突变体M372I菌株。而另一株高酶活天冬氨酸激酶突变体的核苷酸序列如SEQ ID NO:5所示,氨基酸序列如SEQ ID NO:6所示,对比SEQ ID NO:2和SEQ ID NO:6的氨基酸序列,发现379位点的苏氨酸(T)突变为丝氨酸(S),即成功构建了高酶活天冬氨酸激酶单突变体T379S菌株。
(4)天冬氨酸激酶双突变体M372I-T379S的构建
利用TAKaRa质粒提取试剂盒提取实施例2(3)中高酶活单突变体M372I菌株的质粒,利用T379S上游引物5’-TTCCATGAACTCTGCGCTAACACCTGGGTGAGAC-3’,下游引物5’-CACCCAGGTGTTAGCGCAGAGTTCATGGAAGC-3’(划线部分为突变位点)运用实施例2(1)中的PCR反应扩增程序进行突变PCR,并通过实施1(2)的方法将PCR产物转入到大肠杆菌BL21(DE3)感受态中,获得天冬氨酸激酶双突变体M372I-T379S菌株,其天冬氨酸激酶的核苷酸序列如SEQID NO:7所示,氨基酸序列如SEQ ID NO:8所示。
PCR反应体系如下:
实施例3、酶动力学分析及酶学性质表征
(1)粗酶液的分离纯化
将实施例1(2)的重组大肠杆菌菌株(WT)与实施例2中的高酶活突变体(单突变体M372I和T379S)及双突变体M372I-T379S以2%(v/v)接种量分别转接至100mL含卡那霉素的LB液体培养基中,37℃、180r/min过夜培养后,加入IPTG诱导剂(终浓度为1mmol/L),30℃、130r/min,诱导12h。菌液8000r/min离心10min,弃上清液,加10mLPBS重悬菌体,经超声破碎30min,8000r/min离心10min获得的上清液分别为WT粗酶液、M372I粗酶液、T379S粗酶液和M372I-T379S粗酶液。粗酶液经镍柱亲和层析法分离纯化,500mmol/L咪唑洗脱得到AK纯化液分别为WT纯化液、M372I纯化液、T379S纯化液和M372I-T379S纯化液。
将粗酶液和纯化液进行SDS-PAGE蛋白电泳验证,从附图1(b)可以看出粗酶液和纯化液在同一位置处均具有目的条带,表明AK蛋白表达成功,并达到了较理想的纯化效果。
(2)反应动力学分析
本发明的酶动力学分析方法是采用1mL反应体系,测定体系为800mmol/L KCl、10mmol/L L-Asp、100mmol/L Tris-HCl、800mmol/L NH4OH、10mmol/Lβ-巯基乙醇、10.4mmol/L ATP、1.6mmol/L MgSO4,以不同浓度的L-天冬氨酸(分别为0.5mmol/L、1mmol/L、3mmol/L、5mmol/L、7mmol/L、9mmol/L、10mmol/L、12mmol/L、14mmol/L、16mmol/L)为底物,每孔加入20μL酶液,28℃、130r/min反应30min,反应后加入等体积的三氯化铁终止试剂混匀,于波长540nm下测其吸光度,以Hill方程进行非线性拟合见附图2。
野生型AK的最大反应速率Vmax为2.78U/mg·min-1,单突变体M372I、T379S和双突变体M372I-T379S AK的Vmax分别为38.29U/mg·min-1、41.75U/mg·min-1和41.75U/mg·min-1,较野生型AK分别提高了13.77、15.02和15.60倍。野生型AK的Km值为6.18,而单突变体M372I、T379S和双突变体M372I-T379S的Km值分别为4.64、4.66和3.25,表明突变后酶与底物亲和力均有所增强。
(3)酶学性质表征
利用实例3(2)中的反应体系对野生型及突变体AK的纯化液分别进行最适pH、最适温度分析和热稳定性研究,每组进行3次平行实验,测定结果见附图3、4、5。
最适温度研究:反应体系不变,在不同温度下(15℃、20℃、25℃、26℃、28℃、30℃、35℃、40℃、45℃、50℃)测定AK相对酶活力,以最高酶活定义为100%。
最适pH研究:反应体系其它条件不变,反应体系在不同pH(6、6.5、7、7.5、8、8.5、9、9.5、10)下,测定AK相对酶活力。以最高酶活定义为100%。
稳定性研究:在最适pH和最适温度下,相同反应体系,每隔1h测定一次酶活。以0h相对酶活定义为100%。
单突变体M372I、T379S和双突变体M372I-T379S较野生型菌株的最适pH相比均有升高。野生型菌株的最适温度为28℃,单突变体M372I、T379S和双突变体M372I-T379S的最适温度分别为28℃、26℃和30℃,双突变体M372I-T379S表现出良好的耐热性,这对发酵生产具有重要意义。
野生型AK的半衰期为3.5h,单突变体M372I、T379S和双突变体M372I-T379S AK的半衰期约为4.5h、4.4h和5.8h,较野生型延长了1.0、0.9和2.3h,上述结果表明,M372和T379位点突变并未对酶稳定性造成影响,并且突变体比野生型更稳定。
(4)AK与抑制剂及底物结合能力分析
通过微量热泳动仪(Monolith NT.115)对天冬氨酸激酶与抑制剂Lys的结合能力进行分析,测定结果见附图6,通过微量热泳动分析(microscale thermophoresis,MST)得到的解离常数Kd值越小,则表明亲和力越强,反之,亦然。与野生型AK相比较,M372I-T379S突变体与抑制剂Lys解离常数Kd值由1.32mM变为142.38mM,与底物L-Asp解离常数Kd值由686.86mM变为28.88mM,证明M372I-T379S突变体与底物L-Asp结合能力明显增强,与抑制剂结合强度变弱,这可能是酶活力提高的主要原因。
实施例4、工程菌构建及发酵分析
(1)工程菌株构建
利用TAKaRa质粒提取试剂盒提取实施例3中酶学性质显著改善的双突变体M372I-T379S菌株质粒,将其与穿梭载体pEC-XK99E(购自丰晖生物有限公司)分别进行EcR I和BamH I双酶切,胶回收目的产物AK基因片段和线性穿梭载体pEC-XK99E,在16℃恒温金属浴中进行过夜连接,获得pEC-AK重组穿梭表达载体。利用电转化法将pEC-AK重组穿梭表达载体转入到北京棒杆菌原菌中,获得北京棒杆菌重组菌M372I-T379S工程菌的菌落呈现圆形、淡黄色、表面光滑、不透明、中央隆起、边缘整齐,一般不运动,2-3天直径可达1.5-3.0mm的特点。
连接体系如下:
电转化法:
1)取出北京棒杆菌感受态细胞并放在冰上融化,添加pEC-AK重组穿梭表达载体3μL并混匀。
2)立即将上述溶液转移至预冷的0.2cm电转杯中,将电转化杯放入电转化仪中,在电压2500V条件下电击5ms。
3)迅速将lmL电转恢复培养基(蛋白胨5g/L,酵母浸粉2.5g/L,NaCl 10g/L,脑心浸出液18.5g/L,山梨醇91g/L,p H 7.0)加入到电转杯中混匀。
4)将步骤3)混匀的电转杯中溶液转入到无菌1.5mL EP管中,30℃,160rpm,培养3h。
5)将步骤4)获得的菌液8000r/min离心2min,弃上清液800μL,重悬菌体后涂布在含卡那霉素的固体LB平板上,30℃培养36h。
(2)发酵产物氨基酸含量检测
将北京棒杆菌原菌和北京棒杆菌重组菌M372I-T379S工程菌分别以2%(v/v)接种量接入到100mL种子培养基(葡萄糖25g/L,玉米浆20g/L,尿素1.25g/L,KH2PO4 1g/L,MgSO45g/L,pH 7.0),30℃、200rpm培养12后,将其分别以5%(v/v))接菌量转接至100mL发酵培养基(葡萄糖60g/L,玉米浆20g/L,维生素B11mg/L,维生素B6 6mg/L,维生素B12 0.2g/L,生物素0.1mg/L,KH2PO4 1g/L,(NH4)2SO4 20g/L,MgSO4 0.5g/L,MnSO4 0.01g/L,FeSO4 0.01g/L,pH 7.0)中,使其初始OD600=1.0,30℃、200rpm培养0-48h,通过高效液相色谱法对发酵液进行氨基酸含量检测。
每4h收集一次菌株发酵液,经高效液相色谱法检测发现发酵30h后,北京棒杆菌原菌和北京棒杆菌重组菌M372I-T379S工程菌的发酵产物均比较稳定,北京棒杆菌原菌发酵液的总氨基酸含量为48.72g/L,其中L-蛋氨酸、L-苏氨酸、L-异亮氨酸和L-赖氨酸产量分别达到0.14g/L、1.93g/L、4.82g/L和6.78g/L,而北京棒杆菌重组菌M372I-T379S工程菌发酵液的总氨基酸含量高达53.64g/L,其中L-蛋氨酸、L-苏氨酸、L-异亮氨酸和L-赖氨酸产量分别达到0.16g/L、2.68g/L、5.33g/L和8.39g/L,较比北京棒杆菌原菌发酵液氨基酸含量分别增长了14.28%、38.86%、10.58%和23.75%。
<110> 吉林农业大学
<120> 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法
<130> 2018
<160> 8
<170> PatentIn version 3.3
<210> 1
<211> 1319
<212> DNA
<213> Corynebacterium pekinense
<400> 1
atgatcgatg atatcccatg ggcggccgcc tgcagaccag gtctggaatt ccatatggcc 60
ctggtcgtac agaaatatgg cggttcctcg cttgagagtg cggaacgcat tagaaacgtc 120
gctgaacgga tcgttgccac caagaaggct ggaaatgatg tcgtggttgt ccgctccgca 180
atgggagaca ccacggatga acttctagaa cttgcggcgg cagtgaatcc cgttccgcca 240
gctcgtgaaa tggatatgct cctgactgct ggtgagcgta tttctaacgc tctcgtcgcc 300
atggctattg agtcccttgg cgcagaagcc caatctttca cgggctctca ggctggtgtg 360
ctcaccaccg agcgccacgg aaacgcacgc attgttgacg tcacaccggg tcgtgtgcgt 420
gaagcactcg atgagggcaa gatctgcatt gttgctggtt tccagggtgt taataaagaa 480
acccgcgatg tcaccacgtt gggtcgtggt ggttctgaca ccactgcagt tgcgttggca 540
gctgctttga acgctgatgt gtgtgagatt tactcggacg ttgacggtgt gtataccgct 600
gacccgcgca tcgttcctaa tgcacagaag ctggaaaagc tcagcttcga agaaatgctg 660
gaacttgctg ctgttggctc caagattttg gtgctgcgca gtgttgaata cgctcgtgca 720
ttcaatgtgc cacttcgcgt acgctcgtct tatagtaatg atcccggcac tttgattgcc 780
ggctctatgg aggatattcc tgtggaagaa gcagtcctta ccggtgtcgc aaccgacaag 840
tccgaagcca aagtaaccgt tctgggtatt tccgataagc caggcgaggc tgcgaaggtt 900
ttccgtgcgt tggctgatgc agaaatcaac attgacatgg ttctgcagaa cgtctcctct 960
gtggaagacg gcaccaccga catcacgttc acctgccctc gcgctgacgg acgccgtgcg 1020
gtggagatct tgaagaagct tcaggttcag ggcaactgga ccaatgtgct ttacgacgac 1080
caggtcggca aagtctccct cgtgggtgcg ggcatgcagt ctcacccagg tgttaccgca 1140
gagttcatgg aagctctgcg cgatgtcaac gtggacatcg aattgatttc cacctctgag 1200
atccgcattt ctgtgctgat ccgtgaggat gatctggatg ctgctgcacg tgcactgcac 1260
gagcagttcc agcttggcgg cgaagacgaa gccgtcgttt atgcaggcac cggagctaa 1319
<210> 2
<211> 439
<212> PRT
<213> Corynebacterium pekinense
<400> 2
Met Ile Asp Asp Ile Pro Trp Ala Ala Ala Cys Arg Pro Gly Leu Glu
1 5 10 15
Phe His Met Ala Leu Val Val Gln Lys Tyr Gly Gly Ser Ser Leu Glu
20 25 30
Ser Ala Glu Arg Ile Arg Asn Val Ala Glu Arg Ile Val Ala Thr Lys
35 40 45
Lys Ala Gly Asn Asp Val Val Val Val Arg Ser Ala Met Gly Asp Thr
50 55 60
Thr Asp Glu Leu Leu Glu Leu Ala Ala Ala Val Asn Pro Val Pro Pro
65 70 75 80
Ala Arg Glu Met Asp Met Leu Leu Thr Ala Gly Glu Arg Ile Ser Asn
85 90 95
Ala Leu Val Ala Met Ala Ile Glu Ser Leu Gly Ala Glu Ala Gln Ser
100 105 110
Phe Thr Gly Ser Gln Ala Gly Val Leu Thr Thr Glu Arg His Gly Asn
115 120 125
Ala Arg Ile Val Asp Val Thr Pro Gly Arg Val Arg Glu Ala Leu Asp
130 135 140
Glu Gly Lys Ile Cys Ile Val Ala Gly Phe Gln Gly Val Asn Lys Glu
145 150 155 160
Thr Arg Asp Val Thr Thr Leu Gly Arg Gly Gly Ser Asp Thr Thr Ala
165 170 175
Val Ala Leu Ala Ala Ala Leu Asn Ala Asp Val Cys Glu Ile Tyr Ser
180 185 190
Asp Val Asp Gly Val Tyr Thr Ala Asp Pro Arg Ile Val Pro Asn Ala
195 200 205
Gln Lys Leu Glu Lys Leu Ser Phe Glu Glu Met Leu Glu Leu Ala Ala
210 215 220
Val Gly Ser Lys Ile Leu Val Leu Arg Ser Val Glu Tyr Ala Arg Ala
225 230 235 240
Phe Asn Val Pro Leu Arg Val Arg Ser Ser Tyr Ser Asn Asp Pro Gly
245 250 255
Thr Leu Ile Ala Gly Ser Met Glu Asp Ile Pro Val Glu Glu Ala Val
260 265 270
Leu Thr Gly Val Ala Thr Asp Lys Ser Glu Ala Lys Val Thr Val Leu
275 280 285
Gly Ile Ser Asp Lys Pro Gly Glu Ala Ala Lys Val Phe Arg Ala Leu
290 295 300
Ala Asp Ala Glu Ile Asn Ile Asp Met Val Leu Gln Asn Val Ser Ser
305 310 315 320
Val Glu Asp Gly Thr Thr Asp Ile Thr Phe Thr Cys Pro Arg Ala Asp
325 330 335
Gly Arg Arg Ala Val Glu Ile Leu Lys Lys Leu Gln Val Gln Gly Asn
340 345 350
Trp Thr Asn Val Leu Tyr Asp Asp Gln Val Gly Lys Val Ser Leu Val
355 360 365
Gly Ala Gly Met Gln Ser His Pro Gly Val Thr Ala Glu Phe Met Glu
370 375 380
Ala Leu Arg Asp Val Asn Val Asp Ile Glu Leu Ile Ser Thr Ser Glu
385 390 395 400
Ile Arg Ile Ser Val Leu Ile Arg Glu Asp Asp Leu Asp Ala Ala Ala
405 410 415
Arg Ala Leu His Glu Gln Phe Gln Leu Gly Gly Glu Asp Glu Ala Val
420 425 430
Val Tyr Ala Gly Thr Gly Ala
435
<210> 3
<211> 1319
<212> DNA
<213> Corynebacterium pekinense
<400> 3
atgatcgatg atatcccatg ggcggccgcc tgcagaccag gtctggaatt ccatatggcc 60
ctggtcgtac agaaatatgg cggttcctcg cttgagagtg cggaacgcat tagaaacgtc 120
gctgaacgga tcgttgccac caagaaggct ggaaatgatg tcgtggttgt ccgctccgca 180
atgggagaca ccacggatga acttctagaa cttgcggcgg cagtgaatcc cgttccgcca 240
gctcgtgaaa tggatatgct cctgactgct ggtgagcgta tttctaacgc tctcgtcgcc 300
atggctattg agtcccttgg cgcagaagcc caatctttca cgggctctca ggctggtgtg 360
ctcaccaccg agcgccacgg aaacgcacgc attgttgacg tcacaccggg tcgtgtgcgt 420
gaagcactcg atgagggcaa gatctgcatt gttgctggtt tccagggtgt taataaagaa 480
acccgcgatg tcaccacgtt gggtcgtggt ggttctgaca ccactgcagt tgcgttggca 540
gctgctttga acgctgatgt gtgtgagatt tactcggacg ttgacggtgt gtataccgct 600
gacccgcgca tcgttcctaa tgcacagaag ctggaaaagc tcagcttcga agaaatgctg 660
gaacttgctg ctgttggctc caagattttg gtgctgcgca gtgttgaata cgctcgtgca 720
ttcaatgtgc cacttcgcgt acgctcgtct tatagtaatg atcccggcac tttgattgcc 780
ggctctatgg aggatattcc tgtggaagaa gcagtcctta ccggtgtcgc aaccgacaag 840
tccgaagcca aagtaaccgt tctgggtatt tccgataagc caggcgaggc tgcgaaggtt 900
ttccgtgcgt tggctgatgc agaaatcaac attgacatgg ttctgcagaa cgtctcctct 960
gtggaagacg gcaccaccga catcacgttc acctgccctc gcgctgacgg acgccgtgcg 1020
gtggagatct tgaagaagct tcaggttcag ggcaactgga ccaatgtgct ttacgacgac 1080
caggtcggca aagtctccct cgtgggtgcg ggcatacagt ctcacccagg tgttaccgca 1140
gagttcatgg aagctctgcg cgatgtcaac gtggacatcg aattgatttc cacctctgag 1200
atccgcattt ctgtgctgat ccgtgaggat gatctggatg ctgctgcacg tgcactgcac 1260
gagcagttcc agcttggcgg cgaagacgaa gccgtcgttt atgcaggcac cggagctaa 1319
<210> 4
<211> 439
<212> PRT
<213> Corynebacterium pekinense
<400> 4
Met Ile Asp Asp Ile Pro Trp Ala Ala Ala Cys Arg Pro Gly Leu Glu
1 5 10 15
Phe His Met Ala Leu Val Val Gln Lys Tyr Gly Gly Ser Ser Leu Glu
20 25 30
Ser Ala Glu Arg Ile Arg Asn Val Ala Glu Arg Ile Val Ala Thr Lys
35 40 45
Lys Ala Gly Asn Asp Val Val Val Val Arg Ser Ala Met Gly Asp Thr
50 55 60
Thr Asp Glu Leu Leu Glu Leu Ala Ala Ala Val Asn Pro Val Pro Pro
65 70 75 80
Ala Arg Glu Met Asp Met Leu Leu Thr Ala Gly Glu Arg Ile Ser Asn
85 90 95
Ala Leu Val Ala Met Ala Ile Glu Ser Leu Gly Ala Glu Ala Gln Ser
100 105 110
Phe Thr Gly Ser Gln Ala Gly Val Leu Thr Thr Glu Arg His Gly Asn
115 120 125
Ala Arg Ile Val Asp Val Thr Pro Gly Arg Val Arg Glu Ala Leu Asp
130 135 140
Glu Gly Lys Ile Cys Ile Val Ala Gly Phe Gln Gly Val Asn Lys Glu
145 150 155 160
Thr Arg Asp Val Thr Thr Leu Gly Arg Gly Gly Ser Asp Thr Thr Ala
165 170 175
Val Ala Leu Ala Ala Ala Leu Asn Ala Asp Val Cys Glu Ile Tyr Ser
180 185 190
Asp Val Asp Gly Val Tyr Thr Ala Asp Pro Arg Ile Val Pro Asn Ala
195 200 205
Gln Lys Leu Glu Lys Leu Ser Phe Glu Glu Met Leu Glu Leu Ala Ala
210 215 220
Val Gly Ser Lys Ile Leu Val Leu Arg Ser Val Glu Tyr Ala Arg Ala
225 230 235 240
Phe Asn Val Pro Leu Arg Val Arg Ser Ser Tyr Ser Asn Asp Pro Gly
245 250 255
Thr Leu Ile Ala Gly Ser Met Glu Asp Ile Pro Val Glu Glu Ala Val
260 265 270
Leu Thr Gly Val Ala Thr Asp Lys Ser Glu Ala Lys Val Thr Val Leu
275 280 285
Gly Ile Ser Asp Lys Pro Gly Glu Ala Ala Lys Val Phe Arg Ala Leu
290 295 300
Ala Asp Ala Glu Ile Asn Ile Asp Met Val Leu Gln Asn Val Ser Ser
305 310 315 320
Val Glu Asp Gly Thr Thr Asp Ile Thr Phe Thr Cys Pro Arg Ala Asp
325 330 335
Gly Arg Arg Ala Val Glu Ile Leu Lys Lys Leu Gln Val Gln Gly Asn
340 345 350
Trp Thr Asn Val Leu Tyr Asp Asp Gln Val Gly Lys Val Ser Leu Val
355 360 365
Gly Ala Gly Ile Gln Ser His Pro Gly Val Thr Ala Glu Phe Met Glu
370 375 380
Ala Leu Arg Asp Val Asn Val Asp Ile Glu Leu Ile Ser Thr Ser Glu
385 390 395 400
Ile Arg Ile Ser Val Leu Ile Arg Glu Asp Asp Leu Asp Ala Ala Ala
405 410 415
Arg Ala Leu His Glu Gln Phe Gln Leu Gly Gly Glu Asp Glu Ala Val
420 425 430
Val Tyr Ala Gly Thr Gly Ala
435
<210> 5
<211> 1319
<212> DNA
<213> Corynebacterium pekinense
<400> 5
atgatcgatg atatcccatg ggcggccgcc tgcagaccag gtctggaatt ccatatggcc 60
ctggtcgtac agaaatatgg cggttcctcg cttgagagtg cggaacgcat tagaaacgtc 120
gctgaacgga tcgttgccac caagaaggct ggaaatgatg tcgtggttgt ccgctccgca 180
atgggagaca ccacggatga acttctagaa cttgcggcgg cagtgaatcc cgttccgcca 240
gctcgtgaaa tggatatgct cctgactgct ggtgagcgta tttctaacgc tctcgtcgcc 300
atggctattg agtcccttgg cgcagaagcc caatctttca cgggctctca ggctggtgtg 360
ctcaccaccg agcgccacgg aaacgcacgc attgttgacg tcacaccggg tcgtgtgcgt 420
gaagcactcg atgagggcaa gatctgcatt gttgctggtt tccagggtgt taataaagaa 480
acccgcgatg tcaccacgtt gggtcgtggt ggttctgaca ccactgcagt tgcgttggca 540
gctgctttga acgctgatgt gtgtgagatt tactcggacg ttgacggtgt gtataccgct 600
gacccgcgca tcgttcctaa tgcacagaag ctggaaaagc tcagcttcga agaaatgctg 660
gaacttgctg ctgttggctc caagattttg gtgctgcgca gtgttgaata cgctcgtgca 720
ttcaatgtgc cacttcgcgt acgctcgtct tatagtaatg atcccggcac tttgattgcc 780
ggctctatgg aggatattcc tgtggaagaa gcagtcctta ccggtgtcgc aaccgacaag 840
tccgaagcca aagtaaccgt tctgggtatt tccgataagc caggcgaggc tgcgaaggtt 900
ttccgtgcgt tggctgatgc agaaatcaac attgacatgg ttctgcagaa cgtctcctct 960
gtggaagacg gcaccaccga catcacgttc acctgccctc gcgctgacgg acgccgtgcg 1020
gtggagatct tgaagaagct tcaggttcag ggcaactgga ccaatgtgct ttacgacgac 1080
caggtcggca aagtctccct cgtgggtgcg ggcatgcagt ctcacccagg tgttagcgca 1140
gagttcatgg aagctctgcg cgatgtcaac gtggacatcg aattgatttc cacctctgag 1200
atccgcattt ctgtgctgat ccgtgaggat gatctggatg ctgctgcacg tgcactgcac 1260
gagcagttcc agcttggcgg cgaagacgaa gccgtcgttt atgcaggcac cggagctaa 1319
<210> 6
<211> 439
<212> PRT
<213> Corynebacterium pekinense
<400> 6
Met Ile Asp Asp Ile Pro Trp Ala Ala Ala Cys Arg Pro Gly Leu Glu
1 5 10 15
Phe His Met Ala Leu Val Val Gln Lys Tyr Gly Gly Ser Ser Leu Glu
20 25 30
Ser Ala Glu Arg Ile Arg Asn Val Ala Glu Arg Ile Val Ala Thr Lys
35 40 45
Lys Ala Gly Asn Asp Val Val Val Val Arg Ser Ala Met Gly Asp Thr
50 55 60
Thr Asp Glu Leu Leu Glu Leu Ala Ala Ala Val Asn Pro Val Pro Pro
65 70 75 80
Ala Arg Glu Met Asp Met Leu Leu Thr Ala Gly Glu Arg Ile Ser Asn
85 90 95
Ala Leu Val Ala Met Ala Ile Glu Ser Leu Gly Ala Glu Ala Gln Ser
100 105 110
Phe Thr Gly Ser Gln Ala Gly Val Leu Thr Thr Glu Arg His Gly Asn
115 120 125
Ala Arg Ile Val Asp Val Thr Pro Gly Arg Val Arg Glu Ala Leu Asp
130 135 140
Glu Gly Lys Ile Cys Ile Val Ala Gly Phe Gln Gly Val Asn Lys Glu
145 150 155 160
Thr Arg Asp Val Thr Thr Leu Gly Arg Gly Gly Ser Asp Thr Thr Ala
165 170 175
Val Ala Leu Ala Ala Ala Leu Asn Ala Asp Val Cys Glu Ile Tyr Ser
180 185 190
Asp Val Asp Gly Val Tyr Thr Ala Asp Pro Arg Ile Val Pro Asn Ala
195 200 205
Gln Lys Leu Glu Lys Leu Ser Phe Glu Glu Met Leu Glu Leu Ala Ala
210 215 220
Val Gly Ser Lys Ile Leu Val Leu Arg Ser Val Glu Tyr Ala Arg Ala
225 230 235 240
Phe Asn Val Pro Leu Arg Val Arg Ser Ser Tyr Ser Asn Asp Pro Gly
245 250 255
Thr Leu Ile Ala Gly Ser Met Glu Asp Ile Pro Val Glu Glu Ala Val
260 265 270
Leu Thr Gly Val Ala Thr Asp Lys Ser Glu Ala Lys Val Thr Val Leu
275 280 285
Gly Ile Ser Asp Lys Pro Gly Glu Ala Ala Lys Val Phe Arg Ala Leu
290 295 300
Ala Asp Ala Glu Ile Asn Ile Asp Met Val Leu Gln Asn Val Ser Ser
305 310 315 320
Val Glu Asp Gly Thr Thr Asp Ile Thr Phe Thr Cys Pro Arg Ala Asp
325 330 335
Gly Arg Arg Ala Val Glu Ile Leu Lys Lys Leu Gln Val Gln Gly Asn
340 345 350
Trp Thr Asn Val Leu Tyr Asp Asp Gln Val Gly Lys Val Ser Leu Val
355 360 365
Gly Ala Gly Met Gln Ser His Pro Gly Val Ser Ala Glu Phe Met Glu
370 375 380
Ala Leu Arg Asp Val Asn Val Asp Ile Glu Leu Ile Ser Thr Ser Glu
385 390 395 400
Ile Arg Ile Ser Val Leu Ile Arg Glu Asp Asp Leu Asp Ala Ala Ala
405 410 415
Arg Ala Leu His Glu Gln Phe Gln Leu Gly Gly Glu Asp Glu Ala Val
420 425 430
Val Tyr Ala Gly Thr Gly Ala
435
<210> 7
<211> 1319
<212> DNA
<213> Corynebacterium pekinense
<400> 7
atgatcgatg atatcccatg ggcggccgcc tgcagaccag gtctggaatt ccatatggcc 60
ctggtcgtac agaaatatgg cggttcctcg cttgagagtg cggaacgcat tagaaacgtc 120
gctgaacgga tcgttgccac caagaaggct ggaaatgatg tcgtggttgt ccgctccgca 180
atgggagaca ccacggatga acttctagaa cttgcggcgg cagtgaatcc cgttccgcca 240
gctcgtgaaa tggatatgct cctgactgct ggtgagcgta tttctaacgc tctcgtcgcc 300
atggctattg agtcccttgg cgcagaagcc caatctttca cgggctctca ggctggtgtg 360
ctcaccaccg agcgccacgg aaacgcacgc attgttgacg tcacaccggg tcgtgtgcgt 420
gaagcactcg atgagggcaa gatctgcatt gttgctggtt tccagggtgt taataaagaa 480
acccgcgatg tcaccacgtt gggtcgtggt ggttctgaca ccactgcagt tgcgttggca 540
gctgctttga acgctgatgt gtgtgagatt tactcggacg ttgacggtgt gtataccgct 600
gacccgcgca tcgttcctaa tgcacagaag ctggaaaagc tcagcttcga agaaatgctg 660
gaacttgctg ctgttggctc caagattttg gtgctgcgca gtgttgaata cgctcgtgca 720
ttcaatgtgc cacttcgcgt acgctcgtct tatagtaatg atcccggcac tttgattgcc 780
ggctctatgg aggatattcc tgtggaagaa gcagtcctta ccggtgtcgc aaccgacaag 840
tccgaagcca aagtaaccgt tctgggtatt tccgataagc caggcgaggc tgcgaaggtt 900
ttccgtgcgt tggctgatgc agaaatcaac attgacatgg ttctgcagaa cgtctcctct 960
gtggaagacg gcaccaccga catcacgttc acctgccctc gcgctgacgg acgccgtgcg 1020
gtggagatct tgaagaagct tcaggttcag ggcaactgga ccaatgtgct ttacgacgac 1080
caggtcggca aagtctccct cgtgggtgcg ggcatacagt ctcacccagg tgttagcgca 1140
gagttcatgg aagctctgcg cgatgtcaac gtggacatcg aattgatttc cacctctgag 1200
atccgcattt ctgtgctgat ccgtgaggat gatctggatg ctgctgcacg tgcactgcac 1260
gagcagttcc agcttggcgg cgaagacgaa gccgtcgttt atgcaggcac cggagctaa 1319
<210> 8
<211> 439
<212> PRT
<213> Corynebacterium pekinense
<400> 8
Met Ile Asp Asp Ile Pro Trp Ala Ala Ala Cys Arg Pro Gly Leu Glu
1 5 10 15
Phe His Met Ala Leu Val Val Gln Lys Tyr Gly Gly Ser Ser Leu Glu
20 25 30
Ser Ala Glu Arg Ile Arg Asn Val Ala Glu Arg Ile Val Ala Thr Lys
35 40 45
Lys Ala Gly Asn Asp Val Val Val Val Arg Ser Ala Met Gly Asp Thr
50 55 60
Thr Asp Glu Leu Leu Glu Leu Ala Ala Ala Val Asn Pro Val Pro Pro
65 70 75 80
Ala Arg Glu Met Asp Met Leu Leu Thr Ala Gly Glu Arg Ile Ser Asn
85 90 95
Ala Leu Val Ala Met Ala Ile Glu Ser Leu Gly Ala Glu Ala Gln Ser
100 105 110
Phe Thr Gly Ser Gln Ala Gly Val Leu Thr Thr Glu Arg His Gly Asn
115 120 125
Ala Arg Ile Val Asp Val Thr Pro Gly Arg Val Arg Glu Ala Leu Asp
130 135 140
Glu Gly Lys Ile Cys Ile Val Ala Gly Phe Gln Gly Val Asn Lys Glu
145 150 155 160
Thr Arg Asp Val Thr Thr Leu Gly Arg Gly Gly Ser Asp Thr Thr Ala
165 170 175
Val Ala Leu Ala Ala Ala Leu Asn Ala Asp Val Cys Glu Ile Tyr Ser
180 185 190
Asp Val Asp Gly Val Tyr Thr Ala Asp Pro Arg Ile Val Pro Asn Ala
195 200 205
Gln Lys Leu Glu Lys Leu Ser Phe Glu Glu Met Leu Glu Leu Ala Ala
210 215 220
Val Gly Ser Lys Ile Leu Val Leu Arg Ser Val Glu Tyr Ala Arg Ala
225 230 235 240
Phe Asn Val Pro Leu Arg Val Arg Ser Ser Tyr Ser Asn Asp Pro Gly
245 250 255
Thr Leu Ile Ala Gly Ser Met Glu Asp Ile Pro Val Glu Glu Ala Val
260 265 270
Leu Thr Gly Val Ala Thr Asp Lys Ser Glu Ala Lys Val Thr Val Leu
275 280 285
Gly Ile Ser Asp Lys Pro Gly Glu Ala Ala Lys Val Phe Arg Ala Leu
290 295 300
Ala Asp Ala Glu Ile Asn Ile Asp Met Val Leu Gln Asn Val Ser Ser
305 310 315 320
Val Glu Asp Gly Thr Thr Asp Ile Thr Phe Thr Cys Pro Arg Ala Asp
325 330 335
Gly Arg Arg Ala Val Glu Ile Leu Lys Lys Leu Gln Val Gln Gly Asn
340 345 350
Trp Thr Asn Val Leu Tyr Asp Asp Gln Val Gly Lys Val Ser Leu Val
355 360 365
Gly Ala Gly Ile Gln Ser His Pro Gly Val Ser Ala Glu Phe Met Glu
370 375 380
Ala Leu Arg Asp Val Asn Val Asp Ile Glu Leu Ile Ser Thr Ser Glu
385 390 395 400
Ile Arg Ile Ser Val Leu Ile Arg Glu Asp Asp Leu Asp Ala Ala Ala
405 410 415
Arg Ala Leu His Glu Gln Phe Gln Leu Gly Gly Glu Asp Glu Ala Val
420 425 430
Val Tyr Ala Gly Thr Gly Ala
435
Claims (3)
1.一种高酶活天冬氨酸激酶突变体,其特征在于:其氨基酸序列如SEQ ID NO:8所示。
2.权利要求1所述的高酶活天冬氨酸激酶突变体的制备方法,其步骤如下:
1)以北京棒杆菌(Corynebacterium pekinense)的全基因组为模板,设计引物,通过PCR反应获得核苷酸序列如SEQ ID NO:1所示的天冬氨酸激酶AK目的基因片段;
2)利用限制性内切酶EcoRI和NdeI对步骤1)得到的天冬氨酸激酶AK目的基因片段和pET-28a载体进行双酶切后并过夜连接,连接后的产物即为pET-AK重组质粒;
3)以步骤2)得到的pET-AK重组质粒为模板,利用M372N和T379N引物分别对编码AK的氨基酸序列的372位和379位氨基酸进行定点饱和突变PCR,并将PCR产物分别转入到大肠杆菌BL21(DE3)中,获得多种天冬氨酸激酶突变体菌株,通过高通量筛选的方法挑选出高酶活力天冬氨酸激酶突变体M372I和T379S菌株;
PCR引物如下,划线部分为突变位点:
M372N上游引物5’-GTAACACCTGGGTGAGACTGNNNGCCCGCACC-3’
下游引物5’-CTCGTGGGTGCGGGCNNNCAGTCTCACCC-3’
T379N上游引物5’-CATGAACTCTGCNNNAACACCTGGGTGAGACTG-3’
下游引物5’-CACCCAGGTGTTNNNGCAGAGTTCATGGAAGC-3’
4)提取突变体M372I菌株的质粒,利用T379S上游引物5’-TTCCATGAACTCTGCGCTAACACCTGGGTGAGAC-3’,下游引物5’-CACCCAGGTGTTAGCGCAGAGTTCATGGAAGC-3’,划线部分为突变位点;进行突变PCR,并将PCR产物转入到大肠杆菌BL21(DE3)中,获得天冬氨酸激酶突变体M372I-T379S菌株;
5)添加异丙基硫代半乳糖苷至含有天冬氨酸激酶突变体M372I-T379S菌株的LB培养基中,过夜培养诱导蛋白表达;
6)对步骤5)得到的菌液进行离心处理,加入PBS缓冲溶液吹悬菌体,通过超声破碎、离心处理后得到的上清液即为粗酶液,再经镍柱亲和层析法分离纯化,得到天冬氨酸激酶突变体纯化液,即完成了该高酶活天冬氨酸激酶突变体的构建。
3.一种北京棒杆菌重组菌M372I-T379S工程菌,其保藏编号为CGMCC NO.16340,分类名为北京棒杆菌(Corynebacterium pekinense),保藏单位为中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),保藏日期为2018年8月27日。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811305138.7A CN109295028B (zh) | 2018-11-05 | 2018-11-05 | 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811305138.7A CN109295028B (zh) | 2018-11-05 | 2018-11-05 | 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109295028A CN109295028A (zh) | 2019-02-01 |
CN109295028B true CN109295028B (zh) | 2021-12-17 |
Family
ID=65146392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811305138.7A Active CN109295028B (zh) | 2018-11-05 | 2018-11-05 | 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109295028B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111778225A (zh) * | 2020-07-27 | 2020-10-16 | 江南大学 | 一种天冬氨酸激酶突变体及其在生产l-苏氨酸中的应用 |
CN113201514B (zh) * | 2020-10-16 | 2022-09-06 | 中国科学院天津工业生物技术研究所 | 具有天冬氨酸激酶活性的多肽及其在生产氨基酸中的应用 |
CN112725322B (zh) * | 2021-01-31 | 2022-05-10 | 天津大学 | 天冬氨酸酶突变体及编码基因及工程菌 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041871A1 (fr) * | 1995-06-13 | 1996-12-27 | Ajinomoto Co., Inc. | Procede de production de l-lysine par fermentation |
CN103773745A (zh) * | 2012-10-18 | 2014-05-07 | 中粮生物化学(安徽)股份有限公司 | 天冬氨酸激酶iii突变体及其宿主细胞和应用 |
CN105505894A (zh) * | 2014-09-24 | 2016-04-20 | 中国科学院天津工业生物技术研究所 | 天冬氨酸激酶/高丝氨酸脱氢酶突变体及其应用 |
CN106978405A (zh) * | 2016-01-18 | 2017-07-25 | 中国科学院天津工业生物技术研究所 | 天冬氨酸激酶/高丝氨酸脱氢酶突变体及其应用 |
-
2018
- 2018-11-05 CN CN201811305138.7A patent/CN109295028B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041871A1 (fr) * | 1995-06-13 | 1996-12-27 | Ajinomoto Co., Inc. | Procede de production de l-lysine par fermentation |
CN103773745A (zh) * | 2012-10-18 | 2014-05-07 | 中粮生物化学(安徽)股份有限公司 | 天冬氨酸激酶iii突变体及其宿主细胞和应用 |
CN108486082A (zh) * | 2012-10-18 | 2018-09-04 | 中粮生物化学(安徽)股份有限公司 | 天冬氨酸激酶iii突变体及其宿主细胞和应用 |
CN105505894A (zh) * | 2014-09-24 | 2016-04-20 | 中国科学院天津工业生物技术研究所 | 天冬氨酸激酶/高丝氨酸脱氢酶突变体及其应用 |
CN106978405A (zh) * | 2016-01-18 | 2017-07-25 | 中国科学院天津工业生物技术研究所 | 天冬氨酸激酶/高丝氨酸脱氢酶突变体及其应用 |
Non-Patent Citations (1)
Title |
---|
天冬氨酸激酶代谢调控的研究进展;杨宇亭;《食品科学》;20121215;第37卷(第7期);270-275 * |
Also Published As
Publication number | Publication date |
---|---|
CN109295028A (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110248955B (zh) | 新型多肽及使用其产生imp的方法 | |
CN109295028B (zh) | 高酶活天冬氨酸激酶突变体、工程菌及该突变体的制备方法 | |
CN114350692B (zh) | 一种全细胞催化制备脱羧肌肽的方法 | |
CN114736879B (zh) | 热稳定性改善的葡萄糖氧化酶GoxM10突变体E361P及其衍生突变体和应用 | |
CN114438005B (zh) | 一种用于合成靛蓝色素重组菌的构建方法及应用 | |
CN103146772B (zh) | 用乌头酸酶表达弱化和/或酶活性降低的细菌发酵生产l-赖氨酸的方法 | |
CN107858318A (zh) | 异源表达大肠杆菌中dhdpr提高赖氨酸产量的方法 | |
CN105950524A (zh) | 一种高产l-赖氨酸的谷氨酸棒状杆菌工程菌的构建方法 | |
CN114736881B (zh) | 酸稳定性提高的葡萄糖氧化酶GoxM10突变体A4D及其衍生突变体和应用 | |
CN108504617A (zh) | 一种高产l-赖氨酸的大肠杆菌重组菌及其构建方法 | |
CN112662605B (zh) | Yh66_10715基因改造的生产l-异亮氨酸的菌株及其构建方法和应用 | |
CN102234668B (zh) | 谷氨酸的三级发酵制备 | |
CN114736880B (zh) | 酸稳定性提高葡萄糖氧化酶GoxM10的突变体D497N及其衍生突变体和应用 | |
CN112410353A (zh) | 一种fkbS基因、含其的基因工程菌及其制备方法和用途 | |
CN116333953A (zh) | 一种高产胞嘧啶核苷的基因工程菌及其应用 | |
CN115927432A (zh) | 一种产l-氨基酸的谷氨酸棒状杆菌工程菌的构建方法及应用 | |
CN104371964B (zh) | 有氧下可提升重组蛋白质表现的菌株 | |
CN101892228B (zh) | 一种高丙烯酰胺和丙烯腈耐受性产腈水合酶工程菌及应用 | |
JP7620123B2 (ja) | L-リシン生産能が向上したコリネバクテリウム・グルタミカム変異株及びそれを用いたl-リシン生産方法 | |
CN114438002B (zh) | 一种表达磷酸转移酶与非核糖体肽合成酶的细胞及其应用 | |
CN103173504B (zh) | 用乌头酸酶表达弱化和/或酶活性降低的细菌发酵生产l-苏氨酸的方法 | |
CN109929853A (zh) | 嗜热菌来源的热激蛋白基因的应用 | |
CN114751966B (zh) | Yh66_04585蛋白及其相关生物材料在提高精氨酸产量中的应用 | |
US11180754B2 (en) | Polypeptide and method of producing IMP using the same | |
WO2023142853A1 (zh) | 高产苏氨酸基因工程菌的构建方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |